Schwiertz A - Search Results

1

Impact of the Age of Cecal Material Transfer Donors on Alzheimer's Disease Pathology in 5xFAD Mice.

Valeri F, Dos Santos Guilherme M, He F, Stoye NM, Schwiertz A, Endres K. Valeri F, et al. Among authors: schwiertz a. Microorganisms. 2021 Dec 9;9(12):2548. doi: 10.3390/microorganisms9122548. Microorganisms. 2021. PMID: 34946148 Free PMC article.

2

Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.

Brandscheid C, Schuck F, Reinhardt S, Schäfer KH, Pietrzik CU, Grimm M, Hartmann T, Schwiertz A, Endres K. Brandscheid C, et al. Among authors: schwiertz a. J Alzheimers Dis. 2017;56(2):775-788. doi: 10.3233/JAD-160926. J Alzheimers Dis. 2017. PMID: 28035935

3

Dietary Wheat Amylase Trypsin Inhibitors Impact Alzheimer's Disease Pathology in 5xFAD Model Mice.

Dos Santos Guilherme M, Zevallos VF, Pesi A, Stoye NM, Nguyen VTT, Radyushkin K, Schwiertz A, Schmitt U, Schuppan D, Endres K. Dos Santos Guilherme M, et al. Among authors: schwiertz a. Int J Mol Sci. 2020 Aug 31;21(17):6288. doi: 10.3390/ijms21176288. Int J Mol Sci. 2020. PMID: 32878020 Free PMC article.

4

Resilience and the Gut Microbiome: Insights from Chronically Socially Stressed Wild-Type Mice.

Dos Santos Guilherme M, Valeri F, Winter J, Müller MB, Schwiertz A, Endres K. Dos Santos Guilherme M, et al. Among authors: schwiertz a. Microorganisms. 2022 May 24;10(6):1077. doi: 10.3390/microorganisms10061077. Microorganisms. 2022. PMID: 35744594 Free PMC article.

5

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.

Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Bürmann J, Faßbender K, Schwiertz A, Schäfer KH. Unger MM, et al. Among authors: schwiertz a. Parkinsonism Relat Disord. 2016 Nov;32:66-72. doi: 10.1016/j.parkreldis.2016.08.019. Epub 2016 Aug 26. Parkinsonism Relat Disord. 2016. PMID: 27591074

6

Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease.

Schwiertz A, Spiegel J, Dillmann U, Grundmann D, Bürmann J, Faßbender K, Schäfer KH, Unger MM. Schwiertz A, et al. Parkinsonism Relat Disord. 2018 May;50:104-107. doi: 10.1016/j.parkreldis.2018.02.022. Epub 2018 Feb 12. Parkinsonism Relat Disord. 2018. PMID: 29454662

7

Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota.

Weis S, Schwiertz A, Unger MM, Becker A, Faßbender K, Ratering S, Kohl M, Schnell S, Schäfer KH, Egert M. Weis S, et al. Among authors: schwiertz a. NPJ Parkinsons Dis. 2019 Nov 29;5:28. doi: 10.1038/s41531-019-0100-x. eCollection 2019. NPJ Parkinsons Dis. 2019. PMID: 31815177 Free PMC article.

8

[The role of the gut microbiome in idiopathic Parkinson's disease].

Unger MM, Becker A, Keller A, Schäfer KH, Schwiertz A, Oertel WH. Unger MM, et al. Among authors: schwiertz a. Nervenarzt. 2020 Dec;91(12):1085-1095. doi: 10.1007/s00115-020-01011-x. Epub 2020 Oct 6. Nervenarzt. 2020. PMID: 33025073 Review. German.

9

Association between Parkinson's disease and the faecal eukaryotic microbiota.

Weis S, Meisner A, Schwiertz A, Unger MM, Becker A, Faßbender K, Schnell S, Schäfer KH, Egert M. Weis S, et al. Among authors: schwiertz a. NPJ Parkinsons Dis. 2021 Nov 18;7(1):101. doi: 10.1038/s41531-021-00244-0. NPJ Parkinsons Dis. 2021. PMID: 34795317 Free PMC article.

10

Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.

Ritze Y, Bárdos G, Claus A, Ehrmann V, Bergheim I, Schwiertz A, Bischoff SC. Ritze Y, et al. Among authors: schwiertz a. PLoS One. 2014 Jan 27;9(1):e80169. doi: 10.1371/journal.pone.0080169. eCollection 2014. PLoS One. 2014. PMID: 24475018 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page